ABOUT US
ABOUT US
ABOUT US
With decades of combined experience and a foundation in GSK’s legacy, our team delivers innovative solutions across vaccines and biologics.
With decades of combined experience and a foundation in GSK’s legacy, our team delivers innovative solutions across vaccines and biologics.
ABOUT BIODEXTRIS
ABOUT BIODEXTRIS
ABOUT BIODEXTRIS
Built on the legacy of GSK and powered by a state-of-the-art GMP facility, Biodextris is a dedicated biologics CDMO partner for innovators throughout their product journey.
We provide end-to-end services from preclinical to clinical development, offering the agility, reliability, and flexibility needed to bring new therapies to patients. By combining proven expertise with cutting-edge infrastructure, Biodextris helps biopharma partners scale with confidence — from the earliest stages of innovation to delivering life-changing medicines worldwide. We provide expertise in:
Built on the legacy of GSK and powered by a state-of-the-art GMP facility, Biodextris is a dedicated biologics CDMO partner for innovators throughout their product journey.
We provide end-to-end services from preclinical to clinical development, offering the agility, reliability, and flexibility needed to bring new therapies to patients. By combining proven expertise with cutting-edge infrastructure, Biodextris helps biopharma partners scale with confidence — from the earliest stages of innovation to delivering life-changing medicines worldwide. We provide expertise in:
Built on the legacy of GSK and powered by a state-of-the-art GMP facility, Biodextris is a dedicated biologics CDMO partner for innovators throughout their product journey.
We provide end-to-end services from preclinical to clinical development, offering the agility, reliability, and flexibility needed to bring new therapies to patients. By combining proven expertise with cutting-edge infrastructure, Biodextris helps biopharma partners scale with confidence — from the earliest stages of innovation to delivering life-changing medicines worldwide. We provide expertise in:
• Analytical Development & Qualification
• Analytical Development & Qualification
• Process Development
• Process Development
• Analytical Development & Qualification
• Process Development
• QC Release & Stability Testing
• QC Release & Stability Testing
• GMP Biomanufacturing
• GMP Biomanufacturing
• QC Release & Stability Testing
• GMP Biomanufacturing
At Biodextris, we pride ourselves on being a 5F CDMO —
Focused-on-Patients, Friendly, Fast, Flexible, and Future-Driven — delivering reliable results with a human touch and a clear eye on innovation.
Focused-on-Patients
Focused-on-Patients
Focused-on-Patients
Reliability That Saves Lives
Your success is our mission. We deliver with the integrity and consistency patients depend on.
Reliability That Saves Lives
Your success is our mission. We deliver with the integrity and consistency patients depend on.
Friendly
Friendly
Friendly
Human-Centered Partnership
We speak your language — approachable, collaborative, and aligned with your goals.
Human-Centered Partnership
We speak your language — approachable, collaborative, and aligned with your goals.
Flexible
Flexible
Flexible
Built for Complexity
From custom solutions to evolving needs, we adapt to science as it unfolds.
Built for Complexity
From custom solutions to evolving needs, we adapt to science as it unfolds.
Fast
Fast
Fast
Speed With Precision
Rapid timelines without compromising quality — because we know time matters.
Speed With Precision
Rapid timelines without compromising quality — because we know time matters.
Future-Driven
Future-Driven
Future-Driven
Scalable Innovation
Designed for what’s next, we build with commercial thinking from the start to meet scale and cost.
Scalable Innovation
Designed for what’s next, we build with commercial thinking from the start to meet scale and cost.
OUR STORY
OUR STORY
OUR STORY
1999
2002
2004
2005
2015
2021
1999
2002
2004
2005
2015
2021
Intellivax established for adjuvant development
Acquired by ID Biomedical for vaccine development
IDB acquires Shire
influenza division
Acquired by GSK for vaccine
development and production
Biodextris become an
independant vaccines
& biologics CDMO
Acquired by Archimed, a healthcare-focused investment fund.
Intellivax established for adjuvant development
Acquired by ID Biomedical for vaccine development
IDB acquires Shire
influenza division
Acquired by GSK for vaccine
development and production
Biodextris become an
independant vaccines
& biologics CDMO
Acquired by Archimed, a healthcare-focused investment fund.
OUR MANAGEMENT TEAM
OUR MANAGEMENT TEAM
OUR MANAGEMENT TEAM
Clement Fourny
Chief Executive Officer
Rania Lawandi
Chief Financial Officer
Rosemarie Gauthier
Quality Director
Iness Hammami
Director of Project Management
Martin Gagné
Director of Process Development
Alexandre Audy
GMP Manufacturing and CQV Manager
Hugo-Pierre Richard
Analytical Development Manager
Philippe Béland
Business Development Manager
OUR BOARD MEMBERS
OUR BOARD MEMBERS
OUR BOARD MEMBERS
Darren Verlenden
CEO of Single Use Support, USA
Denis Ribon
ARCHIMED, France
Joseph Jammal
Former President & CEO of Clean Biologics, France
Biodextris’ Vision and Positioning from our Chairman
Biodextris’ Vision and Positioning from our Chairman
Biodextris’ Vision and Positioning from our Chairman
In today’s biopharma world, new modalities, complex pipelines, and tight timelines demand more from CDMOs. At Biodextris, we see our mission as serving innovators, not just as a service provider, but as a true partner in advancing breakthrough therapies.
That is why our vision is built on the 5F Norms. We are Focused on patients, delivering quality they can trust. We are Friendly, fostering real collaboration with our clients. We are Flexible, offering solutions for every challenge. We are Fast, moving with speed and precision because time matters. And we are Future-driven, creating scalable and innovative solutions for tomorrow.
This is the spirit of Biodextris, to stand beside innovators with integrity, agility, and purpose, helping transform bold science into medicines that change lives.
In today’s biopharma world, new modalities, complex pipelines, and tight timelines demand more from CDMOs. At Biodextris, we see our mission as serving innovators, not just as a service provider, but as a true partner in advancing breakthrough therapies.
That is why our vision is built on the 5F Norms. We are Focused on patients, delivering quality they can trust. We are Friendly, fostering real collaboration with our clients. We are Flexible, offering solutions for every challenge. We are Fast, moving with speed and precision because time matters. And we are Future-driven, creating scalable and innovative solutions for tomorrow.
This is the spirit of Biodextris, to stand beside innovators with integrity, agility, and purpose, helping transform bold science into medicines that change lives.
OUR FACILITY
OUR FACILITY
OUR FACILITY
Our 32,000 sq. ft. (3,000 m²) state-of-the-art facility is designed
to drive innovation, collaboration, and growth at every stage of
development.
Our 32,000 sq. ft. (3,000 m²) state-of-the-art facility is designed to drive innovation, collaboration, and growth at every stage of
development.
Our 32,000 sq. ft. (3,000 m²) state-of-the-art facility is designed to drive innovation, collaboration, and growth at every stage of development.
32,000 sq. ft
32,000 sq. ft
of custom-designed
CDMO facility
of custom-designed
CDMO facility
6,500 sq. ft
6,500 sq. ft
of GMP biomanufacturing
cleanrooms
of GMP biomanufacturing
cleanrooms
8,000 sq. ft
8,000 sq. ft
of process development,
analytical & QC labs
of process development,
analytical & QC labs
2,500 sq. ft
2,500 sq. ft
2,500 sq. ft
of controlled material
warehousing
of controlled material
warehousing
Description
GET IN TOUCH WITH OUR FRIENDLY TEAM
Please feel welcome to contact our friendly reception staff with any enquiry. We will answer to you shortly!
Please feel welcome to contact our friendly reception staff with any enquiry. We will answer to you shortly!